Cassava Sciences Files 8-K on Financials
Ticker: FLNA · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1069530
| Field | Detail |
|---|---|
| Company | Cassava Sciences INC (FLNA) |
| Form Type | 8-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, filing
TL;DR
Cassava Sciences dropped an 8-K detailing financials and operations - check it out.
AI Summary
Cassava Sciences, Inc. filed an 8-K on March 3, 2025, reporting on its results of operations and financial condition, and also including financial statements and exhibits. The filing details the company's status as a pharmaceutical preparations company incorporated in Delaware with its principal executive offices in Austin, Texas.
Why It Matters
This filing provides an update on Cassava Sciences' financial condition and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant financial and operational updates that may impact a company's stock price, requiring careful investor review.
Key Numbers
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)
Key Players & Entities
- Cassava Sciences, Inc. (company) — Registrant
- March 3, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Austin, Texas (location) — Address of Principal Executive Offices
- 001-41905 (company_id) — Commission File Number
- 91-1911336 (company_id) — I.R.S. Employer Identification No.
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these results are not provided in the excerpt.
When was the earliest event reported in this filing?
The earliest event reported is dated March 3, 2025.
What is Cassava Sciences, Inc.'s primary industry classification?
Cassava Sciences, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS' with SIC code 2834.
Where are Cassava Sciences, Inc.'s principal executive offices located?
The principal executive offices are located at 6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, Texas 78731.
What is the Commission File Number for Cassava Sciences, Inc.?
The Commission File Number for Cassava Sciences, Inc. is 001-41905.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding CASSAVA SCIENCES INC (FLNA).